Mai Nagaoka

Kanazawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Arylacetamide deacetylase attenuates hepatic lipid accumulation under ER stress conditions by regulating iron-dependent oxidative stress.

Arylacetamide deacetylase attenuates hepatic lipid accumulation under ER stress conditions by regulating iron-dependent oxidative stress.

Journal: Toxicology and applied pharmacology

Published: February 11, 2026

Arylacetamide deacetylase deficiency potentiates ketoconazole-induced inhibition of triazolam metabolism in mice.

Arylacetamide deacetylase deficiency potentiates ketoconazole-induced inhibition of triazolam metabolism in mice.

Journal: Drug metabolism and pharmacokinetics

Published: November 10, 2025

Arylacetamide deacetylase regulates hepatic iron homeostasis to protect against carbon tetrachloride-induced ferroptosis.

Arylacetamide deacetylase regulates hepatic iron homeostasis to protect against carbon tetrachloride-induced ferroptosis.

Journal: Archives of toxicology

Published: August 07, 2024

Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology.

Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology.

Journal: Biochemical pharmacology

Published: December 01, 2023

ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver.

ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver.

Journal: Biochemical pharmacology

Published: May 02, 2023

Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut Microbiota.

Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut Microbiota.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: January 12, 2022

Arylacetamide deacetylase knockout mice are sensitive to ketoconazole-induced hepatotoxicity and adrenal insufficiency.

Arylacetamide deacetylase knockout mice are sensitive to ketoconazole-induced hepatotoxicity and adrenal insufficiency.

Journal: Biochemical pharmacology

Published: September 01, 2021

Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans.

Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans.

Journal: Life sciences

Published: April 13, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026